Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
COX6A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics, part of Exact Sciences United States | 292 | 253 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Charcot-Marie-Tooth disease Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease NGS panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
HNL Genomics Connective Tissue Gene Tests United States | 22 | 19 |
|
Atrial fibrillation Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 22 | 19 |
|
Atrioventricular block NGS test HNL Genomics Connective Tissue Gene Tests United States | 9 | 8 |
|
Atrioventricular block Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 9 | 8 |
|
Atrial fibrillation Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 22 | 19 |
|
Comprehensive Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 82 | 71 |
|
Invitae Comprehensive Neuropathies Panel Invitae United States | 201 | 96 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.